Our History

Over the years, Regencell’s CEO Yat-Gai Au witnessed significant improvement of a family friend’s son who had been diagnosed with attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The child was treated by an extraordinary Chinese medicine practitioner and made noticeable improvements after just one month of treatment. Within two years of treatment, the child’s disorder had generally disappeared and was able to live a normal life.

Then in 2014, Regencell’s Chief Operating Officer, James Chung, was admitted as a patient to the same Chinese medicine practitioner for a different illness and experienced the amazing healing capability of the treatment first-hand.

Dr. Chao witnessed many years ago, the improvements in his autistic son which was treated by the same Chinese Medicine practitioner, now Regencell’s strategic partner. In just a few weeks of treatment, he noticed that his son had more eye contacts and interactions with the people around him and also saw more life in the son’s eyes. Following the course of treatment, his son grew up, made good friends, took care of himself in college, graduated with a master’s degree from UC Santa Barbara and is now working in the Silicon Valley, enjoying his career. Dr. Chao’s family is now very much relieved compared to back then when they were so concerned about the child’s well-being and his adaptation to the surroundings. Inspired by this great experience, Dr. Chao decided to immerse himself in TCM, obtained a degree and license in TCM, and joined Regencell in order to help bring this treatment to the next level.

Both James and Dr. Chao were inspired by their experiences and wondered why such beneficial treatments are only available to a small number of patients. They strongly believed that the formula should be more readily available in order to help more people. Yat-Gai established Regencell and James quit his corporate career to join him. Dr. Chao later joined Regencell in 2019. Together, they have made it their mission to research and develop the formula in hopes of bringing this game-changing formula to more patients around the world.

Regencell aims to be the global leader in the research, development and commercialization of Traditional Chinese Medicine (TCM) for the treatment of:

• neurocognitive disorders and degeneration, specifically ADHD and ASD, for which there are unmet medical needs in the global market; and
• infectious diseases affecting people’s immune system such as COVID-19.